A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

Recruiting

Phase 3

Avonex & ZocorA Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

Sponsor:

Alabama Neurology Associates, PC

Code:

NCT00242268

Conditions

Relapsing Remitting Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Simvastatin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-28. This information was provided to ClinicalTrials.gov by Alabama Neurology Associates, PC on 2005-12-07.